TSLA Tesla | $244.50
+1.5% | 10/8/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 10/8/2024 |
EFX Equifax | $286.34
+1.5% | 10/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $315.00 | Low | View details for Oppenheimer rating of Equifax (NYSE:EFX) on 10/8/2024 |
FICO Fair Isaac | $1,988.00
+1.7% | 10/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $1,967.00 -> $2,109.00 | Low | View details for Oppenheimer rating of Fair Isaac (NYSE:FICO) on 10/8/2024 |
SEIC SEI Investments | $69.97
+0.4% | 10/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $80.00 -> $81.00 | Low | View details for Oppenheimer rating of SEI Investments (NASDAQ:SEIC) on 10/8/2024 |
TRU TransUnion | $106.15
+0.6% | 10/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $97.00 -> $118.00 | Low | View details for Oppenheimer rating of TransUnion (NYSE:TRU) on 10/8/2024 |
CION CION Investment | $11.70
-0.6% | 10/8/2024 | Initiated by | Oppenheimer | - | Market Perform | $13.00 | Medium | View details for Oppenheimer rating of CION Investment (NYSE:CION) on 10/8/2024 |
|
ABT Abbott Laboratories | $114.61
+1.1% | 10/8/2024 | Initiated by | Oppenheimer | - | Outperform | $130.00 | Medium | View details for Oppenheimer rating of Abbott Laboratories (NYSE:ABT) on 10/8/2024 |
MSFT Microsoft | $414.71
+1.3% | 10/8/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Medium | View details for Oppenheimer rating of Microsoft (NASDAQ:MSFT) on 10/8/2024 |
CWAN Clearwater Analytics | $25.14
+0.3% | 10/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $31.00 | High | View details for Oppenheimer rating of Clearwater Analytics (NYSE:CWAN) on 10/7/2024 |
XPO XPO | $107.30
+1.9% | 10/4/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $140.00 -> $140.00 | Low | View details for Oppenheimer rating of XPO (NYSE:XPO) on 10/4/2024 |
KMX CarMax | $72.13
-0.2% | 10/4/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $105.00 -> $105.00 | Low | View details for Oppenheimer rating of CarMax (NYSE:KMX) on 10/4/2024 |
APLE Apple Hospitality REIT | $15.18
+0.5% | 10/4/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $17.00 | Medium | View details for Oppenheimer rating of Apple Hospitality REIT (NYSE:APLE) on 10/4/2024 |
GWRE Guidewire Software | $182.58
+0.2% | 10/4/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $185.00 -> $200.00 | Low | View details for Oppenheimer rating of Guidewire Software (NYSE:GWRE) on 10/4/2024 |
SPGI S&P Global | $518.35
+2.4% | 10/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $540.00 -> $590.00 | Low | View details for Oppenheimer rating of S&P Global (NYSE:SPGI) on 10/3/2024 |
MCO Moody's | $470.86
+2.9% | 10/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $492.00 -> $536.00 | Low | View details for Oppenheimer rating of Moody’s (NYSE:MCO) on 10/3/2024 |
HUM Humana | $243.20
+2.9% | 10/3/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $400.00 -> $280.00 | Medium | View details for Oppenheimer rating of Humana (NYSE:HUM) on 10/3/2024 |
LGND Ligand Pharmaceuticals | $102.97
+0.3% | 10/3/2024 | Initiated by | Oppenheimer | - | Outperform | $135.00 | High | View details for Oppenheimer rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 10/3/2024 |
DNTH Dianthus Therapeutics | $27.99
+5.7% | 10/3/2024 | Initiated by | Oppenheimer | - | Outperform | $48.00 | High | View details for Oppenheimer rating of Dianthus Therapeutics (NASDAQ:DNTH) on 10/3/2024 |
BBIO BridgeBio Pharma | $24.73
-0.4% | 10/3/2024 | Initiated by | Oppenheimer | - | Market Perform | | Medium | View details for Oppenheimer rating of BridgeBio Pharma (NASDAQ:BBIO) on 10/3/2024 |
AYI Acuity Brands | $305.43
-0.8% | 10/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $315.00 -> $370.00 | Medium | View details for Oppenheimer rating of Acuity Brands (NYSE:AYI) on 10/2/2024 |
BAC Bank of America | $39.95
0.0% | 10/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $49.00 | Low | View details for Oppenheimer rating of Bank of America (NYSE:BAC) on 10/2/2024 |
CARR Carrier Global | $80.84
+0.5% | 10/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $74.00 -> $88.00 | Low | View details for Oppenheimer rating of Carrier Global (NYSE:CARR) on 10/2/2024 |
C Citigroup | $63.24
+1.0% | 10/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $87.00 -> $92.00 | Low | View details for Oppenheimer rating of Citigroup (NYSE:C) on 10/2/2024 |
GS The Goldman Sachs Group | $496.57
+0.4% | 10/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $548.00 -> $577.00 | Low | View details for Oppenheimer rating of The Goldman Sachs Group (NYSE:GS) on 10/2/2024 |
JPM JPMorgan Chase & Co. | $210.75
-0.1% | 10/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $221.00 -> $234.00 | Low | View details for Oppenheimer rating of JPMorgan Chase & Co. (NYSE:JPM) on 10/2/2024 |
JCI Johnson Controls International | $76.35
+1.1% | 10/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $79.00 -> $86.00 | Low | View details for Oppenheimer rating of Johnson Controls International (NYSE:JCI) on 10/2/2024 |
PHM PulteGroup | $140.16
+0.5% | 10/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $151.00 -> $168.00 | Low | View details for Oppenheimer rating of PulteGroup (NYSE:PHM) on 10/2/2024 |
TOL Toll Brothers | $151.17
+0.5% | 10/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $168.00 -> $189.00 | Low | View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 10/2/2024 |
TPH Tri Pointe Homes | $43.63
+0.0% | 10/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $56.00 | Low | View details for Oppenheimer rating of Tri Pointe Homes (NYSE:TPH) on 10/2/2024 |
USB U.S. Bancorp | $44.26
-0.5% | 10/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $54.00 -> $57.00 | Medium | View details for Oppenheimer rating of U.S. Bancorp (NYSE:USB) on 10/2/2024 |
BKSY BlackSky Technology | $5.76
+3.2% | 10/2/2024 | Initiated by | Oppenheimer | - | Outperform | $10.00 | High | View details for Oppenheimer rating of BlackSky Technology (NYSE:BKSY) on 10/2/2024 |
ONTO Onto Innovation | $208.83
+1.0% | 10/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $260.00 -> $275.00 | Low | View details for Oppenheimer rating of Onto Innovation (NYSE:ONTO) on 10/1/2024 |
AAPL Apple | $225.77
+1.8% | 10/1/2024 | Reiterated by | Oppenheimer | - | Buy | $250.00 | High | View details for Oppenheimer rating of Apple (NASDAQ:AAPL) on 10/1/2024 |
ML MoneyLion | $40.27
+0.6% | 10/1/2024 | Initiated by | Oppenheimer | - | Market Perform | | High | View details for Oppenheimer rating of MoneyLion (NYSE:ML) on 10/1/2024 |
PGY Pagaya Technologies | $10.13
-0.4% | 10/1/2024 | Initiated by | Oppenheimer | - | Outperform | $12.00 | Medium | View details for Oppenheimer rating of Pagaya Technologies (NASDAQ:PGY) on 10/1/2024 |
SN SharkNinja | $109.62
+1.2% | 10/1/2024 | Initiated by | Oppenheimer | - | Outperform | $120.00 | Medium | View details for Oppenheimer rating of SharkNinja (NYSE:SN) on 10/1/2024 |
FI Fiserv | $187.88
+1.6% | 10/1/2024 | Initiated by | Oppenheimer | - | Outperform | $170.00 -> $203.00 | Medium | View details for Oppenheimer rating of Fiserv (NYSE:FI) on 10/1/2024 |
FIS Fidelity National Information Services | $85.91
+1.9% | 10/1/2024 | Initiated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Fidelity National Information Services (NYSE:FIS) on 10/1/2024 |
GPN Global Payments | $98.82
+1.3% | 10/1/2024 | Initiated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Global Payments (NYSE:GPN) on 10/1/2024 |
IMXI International Money Express | $17.21
-0.5% | 10/1/2024 | Initiated by | Oppenheimer | - | Market Perform | | High | View details for Oppenheimer rating of International Money Express (NASDAQ:IMXI) on 10/1/2024 |
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one.
And my team of experts and I believe that a BIG move is right around the corner.
That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now |
JKHY Jack Henry & Associates | $181.29
+0.8% | 10/1/2024 | Initiated by | Oppenheimer | - | Outperform | $181.00 -> $206.00 | High | View details for Oppenheimer rating of Jack Henry & Associates (NASDAQ:JKHY) on 10/1/2024 |
MA Mastercard | $497.06
+1.2% | 10/1/2024 | Initiated by | Oppenheimer | - | Outperform | $591.00 | Low | View details for Oppenheimer rating of Mastercard (NYSE:MA) on 10/1/2024 |
NYAX Nayax | $25.35
-0.6% | 10/1/2024 | Initiated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of Nayax (NASDAQ:NYAX) on 10/1/2024 |
PYPL PayPal | $81.16
+1.1% | 10/1/2024 | Initiated by | Oppenheimer | - | Market Perform | | Low | View details for Oppenheimer rating of PayPal (NASDAQ:PYPL) on 10/1/2024 |
SQ Block | $68.25
+3.9% | 10/1/2024 | Initiated by | Oppenheimer | - | Market Perform | | Medium | View details for Oppenheimer rating of Block (NYSE:SQ) on 10/1/2024 |
V Visa | $274.96
+0.4% | 10/1/2024 | Initiated by | Oppenheimer | - | Outperform | $289.00 -> $318.00 | Low | View details for Oppenheimer rating of Visa (NYSE:V) on 10/1/2024 |
FOUR Shift4 Payments | $91.96
+1.3% | 10/1/2024 | Initiated by | Oppenheimer | - | Outperform | $109.00 | Medium | View details for Oppenheimer rating of Shift4 Payments (NYSE:FOUR) on 10/1/2024 |
EEFT Euronet Worldwide | $96.03
0.0% | 10/1/2024 | Initiated by | Oppenheimer | - | Outperform | $121.00 | High | View details for Oppenheimer rating of Euronet Worldwide (NASDAQ:EEFT) on 10/1/2024 |
CMG Chipotle Mexican Grill | $57.99
+2.2% | 9/30/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $65.00 -> $65.00 | Low | View details for Oppenheimer rating of Chipotle Mexican Grill (NYSE:CMG) on 9/30/2024 |
UBER Uber Technologies | $76.17
+2.1% | 9/27/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $90.00 -> $95.00 | Low | View details for Oppenheimer rating of Uber Technologies (NYSE:UBER) on 9/27/2024 |
DASH DoorDash | $143.30
+0.9% | 9/27/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $145.00 -> $160.00 | Medium | View details for Oppenheimer rating of DoorDash (NASDAQ:DASH) on 9/27/2024 |
KYMR Kymera Therapeutics | $43.04
+2.0% | 9/27/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $52.00 -> $56.00 | Low | View details for Oppenheimer rating of Kymera Therapeutics (NASDAQ:KYMR) on 9/27/2024 |
EMR Emerson Electric | $109.42
-2.8% | 9/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $120.00 -> $125.00 | High | View details for Oppenheimer rating of Emerson Electric (NYSE:EMR) on 9/26/2024 |
FLUT Flutter Entertainment | $235.98
+0.2% | 9/26/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $255.00 -> $300.00 | Low | View details for Oppenheimer rating of Flutter Entertainment (NYSE:FLUT) on 9/26/2024 |
GEV GE Vernova | $264.27
+0.7% | 9/26/2024 | Initiated by | Oppenheimer | - | Market Perform | | Medium | View details for Oppenheimer rating of GE Vernova (NYSE:GEV) on 9/26/2024 |
VKTX Viking Therapeutics | $66.68
+5.8% | 9/25/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $138.00 -> $138.00 | Medium | View details for Oppenheimer rating of Viking Therapeutics (NASDAQ:VKTX) on 9/25/2024 |
GOOG Alphabet | $165.70
+0.8% | 9/25/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $210.00 -> $185.00 | Low | View details for Oppenheimer rating of Alphabet (NASDAQ:GOOG) on 9/25/2024 |
PRGS Progress Software | $66.02
+0.3% | 9/25/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $66.00 -> $70.00 | High | View details for Oppenheimer rating of Progress Software (NASDAQ:PRGS) on 9/25/2024 |
MGRC McGrath RentCorp | $106.90
-1.7% | 9/25/2024 | Initiated by | Oppenheimer | - | Outperform | $120.00 | Low | View details for Oppenheimer rating of McGrath RentCorp (NASDAQ:MGRC) on 9/25/2024 |
UCTT Ultra Clean | $38.38
-1.1% | 9/25/2024 | Initiated by | Oppenheimer | - | Outperform | $70.00 | High | View details for Oppenheimer rating of Ultra Clean (NASDAQ:UCTT) on 9/25/2024 |
ONTO Onto Innovation | $208.83
+1.0% | 9/25/2024 | Initiated by | Oppenheimer | - | Outperform | $260.00 | Medium | View details for Oppenheimer rating of Onto Innovation (NYSE:ONTO) on 9/25/2024 |
KLAC KLA | $783.90
+0.3% | 9/25/2024 | Initiated by | Oppenheimer | - | Market Perform | $750.00 | Low | View details for Oppenheimer rating of KLA (NASDAQ:KLAC) on 9/25/2024 |
ICHR Ichor | $30.59
-1.6% | 9/25/2024 | Initiated by | Oppenheimer | - | Market Perform | $35.00 | Low | View details for Oppenheimer rating of Ichor (NASDAQ:ICHR) on 9/25/2024 |
CDNS Cadence Design Systems | $270.15
+2.8% | 9/25/2024 | Initiated by | Oppenheimer | - | Underperform | $225.00 | Low | View details for Oppenheimer rating of Cadence Design Systems (NASDAQ:CDNS) on 9/25/2024 |
BRZE Braze | $29.97
-1.0% | 9/24/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $51.00 | High | View details for Oppenheimer rating of Braze (NASDAQ:BRZE) on 9/24/2024 |
COMP Compass | $5.74
+1.2% | 9/24/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $6.00 -> $8.00 | High | View details for Oppenheimer rating of Compass (NYSE:COMP) on 9/24/2024 |
HD Home Depot | $414.23
+1.5% | 9/24/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $345.00 -> $400.00 | High | View details for Oppenheimer rating of Home Depot (NYSE:HD) on 9/24/2024 |
ENGN enGene | $7.10
+6.1% | 9/24/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $30.00 -> $30.00 | High | View details for Oppenheimer rating of enGene (NASDAQ:ENGN) on 9/24/2024 |
PINS Pinterest | $32.93
+1.1% | 9/24/2024 | Initiated by | Oppenheimer | - | Outperform | $45.00 | High | View details for Oppenheimer rating of Pinterest (NYSE:PINS) on 9/24/2024 |
LOW Lowe's Companies | $273.27
+1.8% | 9/24/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $230.00 -> $305.00 | Low | View details for Oppenheimer rating of Lowe’s Companies (NYSE:LOW) on 9/24/2024 |
CAPR Capricor Therapeutics | $19.33
+6.9% | 9/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 -> $15.00 | High | View details for Oppenheimer rating of Capricor Therapeutics (NASDAQ:CAPR) on 9/23/2024 |
TEAM Atlassian | $168.02
+0.3% | 9/23/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $230.00 -> $230.00 | Low | View details for Oppenheimer rating of Atlassian (NASDAQ:TEAM) on 9/23/2024 |
ADUS Addus HomeCare | $129.02
+3.4% | 9/23/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $140.00 -> $145.00 | Low | View details for Oppenheimer rating of Addus HomeCare (NASDAQ:ADUS) on 9/23/2024 |
MRNS Marinus Pharmaceuticals | $1.74
-5.9% | 9/23/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $6.00 | High | View details for Oppenheimer rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 9/23/2024 |
GLW Corning | $44.59
+1.1% | 9/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $47.00 -> $51.00 | Medium | View details for Oppenheimer rating of Corning (NYSE:GLW) on 9/20/2024 |
HUBS HubSpot | $532.08
+1.9% | 9/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $625.00 -> $625.00 | Medium | View details for Oppenheimer rating of HubSpot (NYSE:HUBS) on 9/19/2024 |
TYRA Tyra Biosciences | $21.64
+3.8% | 9/19/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $33.00 | High | View details for Oppenheimer rating of Tyra Biosciences (NASDAQ:TYRA) on 9/19/2024 |
TMUS T-Mobile US | $211.17
+1.4% | 9/19/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $215.00 | Medium | View details for Oppenheimer rating of T-Mobile US (NASDAQ:TMUS) on 9/19/2024 |
BLDR Builders FirstSource | $193.48
+0.7% | 9/18/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $205.00 -> $225.00 | High | View details for Oppenheimer rating of Builders FirstSource (NYSE:BLDR) on 9/18/2024 |
CAPR Capricor Therapeutics | $19.33
+6.9% | 9/17/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $15.00 | Medium | View details for Oppenheimer rating of Capricor Therapeutics (NASDAQ:CAPR) on 9/17/2024 |
RXO RXO | $27.62
+1.5% | 9/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $31.00 -> $31.00 | Low | View details for Oppenheimer rating of RXO (NYSE:RXO) on 9/17/2024 |
VVI Viad | $35.59
-0.7% | 9/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $41.00 -> $41.00 | Low | View details for Oppenheimer rating of Viad (NYSE:VVI) on 9/17/2024 |
ASND Ascendis Pharma A/S | $132.05
-5.1% | 9/17/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $180.00 -> $190.00 | High | View details for Oppenheimer rating of Ascendis Pharma A/S (NASDAQ:ASND) on 9/17/2024 |
ZNTL Zentalis Pharmaceuticals | $3.04
-2.3% | 9/16/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $20.00 -> $20.00 | High | View details for Oppenheimer rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 9/16/2024 |
ENSG The Ensign Group | $145.28
+1.3% | 9/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $155.00 -> $165.00 | Low | View details for Oppenheimer rating of The Ensign Group (NASDAQ:ENSG) on 9/16/2024 |
TLSI TriSalus Life Sciences | $4.42
-0.5% | 9/16/2024 | Initiated by | Oppenheimer | - | Outperform | $10.00 | Low | View details for Oppenheimer rating of TriSalus Life Sciences (NASDAQ:TLSI) on 9/16/2024 |
ADBE Adobe | $496.24
+1.8% | 9/13/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $625.00 -> $625.00 | High | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 9/13/2024 |
JEF Jefferies Financial Group | $63.64
+0.6% | 9/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $64.00 -> $66.00 | Low | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 9/13/2024 |
MRNA Moderna | $58.39
-0.6% | 9/13/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | High | View details for Oppenheimer rating of Moderna (NASDAQ:MRNA) on 9/13/2024 |
SABS SAB Biotherapeutics | $2.67
-2.6% | 9/12/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $12.00 | Low | View details for Oppenheimer rating of SAB Biotherapeutics (NASDAQ:SABS) on 9/12/2024 |
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one.
And my team of experts and I believe that a BIG move is right around the corner.
That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now |
EW Edwards Lifesciences | $68.55
+6.2% | 9/12/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $90.00 -> $90.00 | Low | View details for Oppenheimer rating of Edwards Lifesciences (NYSE:EW) on 9/12/2024 |
ZWS Zurn Elkay Water Solutions | $36.00
-1.9% | 9/12/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $37.00 -> $37.00 | Low | View details for Oppenheimer rating of Zurn Elkay Water Solutions (NYSE:ZWS) on 9/12/2024 |
MOD Modine Manufacturing | $132.77
-0.5% | 9/12/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $135.00 -> $135.00 | Low | View details for Oppenheimer rating of Modine Manufacturing (NYSE:MOD) on 9/12/2024 |
BIOX Bioceres Crop Solutions | $7.45
-2.7% | 9/11/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $16.00 | Low | View details for Oppenheimer rating of Bioceres Crop Solutions (NASDAQ:BIOX) on 9/11/2024 |
IFF International Flavors & Fragrances | $102.49
+1.7% | 9/11/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $116.00 -> $117.00 | Low | View details for Oppenheimer rating of International Flavors & Fragrances (NYSE:IFF) on 9/11/2024 |
AVBP ArriVent BioPharma | $27.39
-0.2% | 9/10/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $35.00 -> $39.00 | Low | View details for Oppenheimer rating of ArriVent BioPharma (NASDAQ:AVBP) on 9/10/2024 |
ORCL Oracle | $174.43
+2.6% | 9/10/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Medium | View details for Oppenheimer rating of Oracle (NYSE:ORCL) on 9/10/2024 |
AAPL Apple | $225.77
+1.8% | 9/10/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $250.00 -> $250.00 | Low | View details for Oppenheimer rating of Apple (NASDAQ:AAPL) on 9/10/2024 |
RLAY Relay Therapeutics | $6.25
-1.4% | 9/10/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | High | View details for Oppenheimer rating of Relay Therapeutics (NASDAQ:RLAY) on 9/10/2024 |
NDAQ Nasdaq | $72.19
+1.9% | 9/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $78.00 -> $80.00 | Low | View details for Oppenheimer rating of Nasdaq (NASDAQ:NDAQ) on 9/9/2024 |
LYV Live Nation Entertainment | $111.61
+0.7% | 9/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $110.00 -> $120.00 | Low | View details for Oppenheimer rating of Live Nation Entertainment (NYSE:LYV) on 9/6/2024 |
PHVS Pharvaris | $17.90
-1.5% | 9/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $38.00 -> $42.00 | Low | View details for Oppenheimer rating of Pharvaris (NASDAQ:PHVS) on 9/6/2024 |
COST Costco Wholesale | $890.42
+1.9% | 9/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $925.00 -> $955.00 | Low | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 9/6/2024 |
DPZ Domino's Pizza | $411.21
+0.3% | 9/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $510.00 -> $490.00 | Low | View details for Oppenheimer rating of Domino’s Pizza (NYSE:DPZ) on 9/6/2024 |
GWRE Guidewire Software | $182.58
+0.2% | 9/6/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $170.00 -> $185.00 | Low | View details for Oppenheimer rating of Guidewire Software (NYSE:GWRE) on 9/6/2024 |
AI C3.ai | $24.45
+1.4% | 9/5/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $40.00 -> $40.00 | Low | View details for Oppenheimer rating of C3.ai (NYSE:AI) on 9/5/2024 |
BASE Couchbase | $15.36
-0.3% | 9/5/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $23.00 | Low | View details for Oppenheimer rating of Couchbase (NASDAQ:BASE) on 9/5/2024 |
PNST Pinstripes | $0.65
-3.0% | 9/5/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $6.00 -> $5.00 | Low | View details for Oppenheimer rating of Pinstripes (NYSE:PNST) on 9/5/2024 |
ASND Ascendis Pharma A/S | $132.05
-5.1% | 9/5/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $180.00 | Low | View details for Oppenheimer rating of Ascendis Pharma A/S (NASDAQ:ASND) on 9/5/2024 |
NRIX Nurix Therapeutics | $22.00
+2.1% | 9/4/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $27.00 -> $30.00 | Low | View details for Oppenheimer rating of Nurix Therapeutics (NASDAQ:NRIX) on 9/4/2024 |
ASAN Asana | $11.69
+3.1% | 9/4/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $23.00 -> $20.00 | Low | View details for Oppenheimer rating of Asana (NYSE:ASAN) on 9/4/2024 |
CSL Carlisle Companies | $460.28
-1.3% | 9/4/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $475.00 -> $480.00 | Low | View details for Oppenheimer rating of Carlisle Companies (NYSE:CSL) on 9/4/2024 |
PRAX Praxis Precision Medicines | $64.77
+3.6% | 9/4/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $134.00 -> $143.00 | Low | View details for Oppenheimer rating of Praxis Precision Medicines (NASDAQ:PRAX) on 9/4/2024 |
ZS Zscaler | $176.93
+2.8% | 9/4/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $260.00 -> $230.00 | Low | View details for Oppenheimer rating of Zscaler (NASDAQ:ZS) on 9/4/2024 |
ADBE Adobe | $496.24
+1.8% | 9/4/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $580.00 -> $625.00 | Low | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 9/4/2024 |
DYN Dyne Therapeutics | $33.13
+4.6% | 9/3/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $55.00 -> $55.00 | Low | View details for Oppenheimer rating of Dyne Therapeutics (NASDAQ:DYN) on 9/3/2024 |
BLDR Builders FirstSource | $193.48
+0.7% | 9/3/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $190.00 -> $205.00 | Low | View details for Oppenheimer rating of Builders FirstSource (NYSE:BLDR) on 9/3/2024 |
FICO Fair Isaac | $1,988.00
+1.7% | 9/3/2024 | Initiated by | Oppenheimer | - | Outperform | $1,967.00 | Low | View details for Oppenheimer rating of Fair Isaac (NYSE:FICO) on 9/3/2024 |
ADSK Autodesk | $275.08
+2.9% | 8/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $275.00 -> $300.00 | Low | View details for Oppenheimer rating of Autodesk (NASDAQ:ADSK) on 8/30/2024 |
ULTA Ulta Beauty | $364.52
-1.5% | 8/30/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $450.00 -> $435.00 | Low | View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 8/30/2024 |
ESTC Elastic | $76.46
-0.9% | 8/30/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $150.00 -> $125.00 | Low | View details for Oppenheimer rating of Elastic (NYSE:ESTC) on 8/30/2024 |
MDB MongoDB | $259.46
+0.0% | 8/30/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $300.00 -> $350.00 | Low | View details for Oppenheimer rating of MongoDB (NASDAQ:MDB) on 8/30/2024 |
CRM Salesforce | $291.57
+2.5% | 8/29/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $280.00 -> $300.00 | Low | View details for Oppenheimer rating of Salesforce (NYSE:CRM) on 8/29/2024 |
CRWD CrowdStrike | $293.01
+2.1% | 8/29/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $450.00 -> $365.00 | Low | View details for Oppenheimer rating of CrowdStrike (NASDAQ:CRWD) on 8/29/2024 |
UTHR United Therapeutics | $355.79
+1.7% | 8/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $400.00 -> $575.00 | Low | View details for Oppenheimer rating of United Therapeutics (NASDAQ:UTHR) on 8/28/2024 |
MNKD MannKind | $6.46
+1.9% | 8/28/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $12.00 | Low | View details for Oppenheimer rating of MannKind (NASDAQ:MNKD) on 8/28/2024 |
ENGN enGene | $7.10
+6.1% | 8/28/2024 | Initiated by | Oppenheimer | - | Outperform | $30.00 | Low | View details for Oppenheimer rating of enGene (NASDAQ:ENGN) on 8/28/2024 |
SABS SAB Biotherapeutics | $2.67
-2.6% | 8/28/2024 | Initiated by | Oppenheimer | - | Outperform | $12.00 | Low | View details for Oppenheimer rating of SAB Biotherapeutics (NASDAQ:SABS) on 8/28/2024 |
ENVX Enovix | $11.82
-2.4% | 8/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $36.00 | Low | View details for Oppenheimer rating of Enovix (NASDAQ:ENVX) on 8/26/2024 |
TRDA Entrada Therapeutics | $16.39
-0.9% | 8/26/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $25.00 | Low | View details for Oppenheimer rating of Entrada Therapeutics (NASDAQ:TRDA) on 8/26/2024 |
DG Dollar General | $83.55
-0.2% | 8/26/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Dollar General (NYSE:DG) on 8/26/2024 |
SBUX Starbucks | $96.21
+0.1% | 8/26/2024 | Reiterated by | Oppenheimer | - | Market Perform -> Market Perform | | Low | View details for Oppenheimer rating of Starbucks (NASDAQ:SBUX) on 8/26/2024 |
CSIQ Canadian Solar | $15.63
-10.5% | 8/23/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $43.00 -> $27.00 | Low | View details for Oppenheimer rating of Canadian Solar (NASDAQ:CSIQ) on 8/23/2024 |
ADI Analog Devices | $229.40
+1.3% | 8/22/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $245.00 -> $245.00 | Low | View details for Oppenheimer rating of Analog Devices (NASDAQ:ADI) on 8/22/2024 |
ALC Alcon | $95.91
+0.5% | 8/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $103.00 -> $110.00 | N/A | View details for Oppenheimer rating of Alcon (NYSE:ALC) on 8/22/2024 |
TOL Toll Brothers | $151.17
+0.5% | 8/22/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $157.00 -> $168.00 | Low | View details for Oppenheimer rating of Toll Brothers (NYSE:TOL) on 8/22/2024 |
CRGO Freightos | $1.37
-2.8% | 8/21/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $4.50 -> $3.50 | Low | View details for Oppenheimer rating of Freightos (NASDAQ:CRGO) on 8/21/2024 |
MDT Medtronic | $88.14
+1.3% | 8/21/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $92.00 -> $94.00 | Low | View details for Oppenheimer rating of Medtronic (NYSE:MDT) on 8/21/2024 |
PANW Palo Alto Networks | $355.13
+5.1% | 8/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $390.00 -> $410.00 | Low | View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 8/20/2024 |
GWRE Guidewire Software | $182.58
+0.2% | 8/20/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $140.00 -> $170.00 | Low | View details for Oppenheimer rating of Guidewire Software (NYSE:GWRE) on 8/20/2024 |
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one.
And my team of experts and I believe that a BIG move is right around the corner.
That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now |
ACA Arcosa | $92.94
-0.5% | 8/19/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $100.00 -> $105.00 | Low | View details for Oppenheimer rating of Arcosa (NYSE:ACA) on 8/19/2024 |
SACH Sachem Capital | $2.44
+0.8% | 8/19/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $4.50 -> $4.00 | N/A | View details for Oppenheimer rating of Sachem Capital (NYSEAMERICAN:SACH) on 8/19/2024 |
KALA KALA BIO | $5.31
-0.7% | 8/19/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $15.00 -> $15.00 | Low | View details for Oppenheimer rating of KALA BIO (NASDAQ:KALA) on 8/19/2024 |
DMAC DiaMedica Therapeutics | $4.65
+6.4% | 8/16/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $6.00 -> $6.00 | Low | View details for Oppenheimer rating of DiaMedica Therapeutics (NASDAQ:DMAC) on 8/16/2024 |
CARR Carrier Global | $80.84
+0.5% | 8/16/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $74.00 | Low | View details for Oppenheimer rating of Carrier Global (NYSE:CARR) on 8/16/2024 |
ULTA Ulta Beauty | $364.52
-1.5% | 8/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $450.00 -> $450.00 | Low | View details for Oppenheimer rating of Ulta Beauty (NASDAQ:ULTA) on 8/15/2024 |
SG Sweetgreen | $38.19
+9.6% | 8/15/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $36.00 -> $40.00 | Low | View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 8/15/2024 |
ACHV Achieve Life Sciences | $5.27
+2.5% | 8/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $11.00 | Low | View details for Oppenheimer rating of Achieve Life Sciences (NASDAQ:ACHV) on 8/15/2024 |
AVBP ArriVent BioPharma | $27.39
-0.2% | 8/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $35.00 -> $35.00 | Low | View details for Oppenheimer rating of ArriVent BioPharma (NASDAQ:AVBP) on 8/15/2024 |
WMS Advanced Drainage Systems | $153.67
-0.5% | 8/15/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $192.00 -> $192.00 | Low | View details for Oppenheimer rating of Advanced Drainage Systems (NYSE:WMS) on 8/15/2024 |
VXRT Vaxart | $0.78
-3.7% | 8/15/2024 | Initiated by | Oppenheimer | - | Outperform | $4.00 | Low | View details for Oppenheimer rating of Vaxart (NASDAQ:VXRT) on 8/15/2024 |
PRAX Praxis Precision Medicines | $64.77
+3.6% | 8/14/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $134.00 -> $134.00 | Low | View details for Oppenheimer rating of Praxis Precision Medicines (NASDAQ:PRAX) on 8/14/2024 |
RGLS Regulus Therapeutics | $1.55
-9.4% | 8/14/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $7.00 | Low | View details for Oppenheimer rating of Regulus Therapeutics (NASDAQ:RGLS) on 8/14/2024 |
CNTA Centessa Pharmaceuticals | $16.08
+3.7% | 8/14/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $14.00 | Low | View details for Oppenheimer rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 8/14/2024 |
GANX Gain Therapeutics | $1.98
-7.0% | 8/14/2024 | Reiterated by | Oppenheimer | - | Outperform | $8.00 | Low | View details for Oppenheimer rating of Gain Therapeutics (NASDAQ:GANX) on 8/14/2024 |
TGT Target | $151.32
+1.6% | 8/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $200.00 -> $180.00 | Low | View details for Oppenheimer rating of Target (NYSE:TGT) on 8/14/2024 |
FLUT Flutter Entertainment | $235.98
+0.2% | 8/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $240.00 -> $255.00 | Low | View details for Oppenheimer rating of Flutter Entertainment (NYSE:FLUT) on 8/14/2024 |
PRTA Prothena | $16.69
+0.6% | 8/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $66.00 -> $62.00 | Low | View details for Oppenheimer rating of Prothena (NASDAQ:PRTA) on 8/14/2024 |
QUIK QuickLogic | $8.16
-0.1% | 8/14/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $16.00 -> $13.00 | Low | View details for Oppenheimer rating of QuickLogic (NASDAQ:QUIK) on 8/14/2024 |
NRIX Nurix Therapeutics | $22.00
+2.1% | 8/14/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $27.00 | Low | View details for Oppenheimer rating of Nurix Therapeutics (NASDAQ:NRIX) on 8/14/2024 |
CATX Perspective Therapeutics | $13.17
+0.3% | 8/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $19.00 -> $17.00 | Low | View details for Oppenheimer rating of Perspective Therapeutics (NYSE:CATX) on 8/13/2024 |
ATXS Astria Therapeutics | $11.21
-3.9% | 8/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $26.00 | Low | View details for Oppenheimer rating of Astria Therapeutics (NASDAQ:ATXS) on 8/13/2024 |
MAIN Main Street Capital | $50.74
-0.5% | 8/13/2024 | Target Raised by | Oppenheimer | - | Market Perform -> Market Perform | $43.00 -> $44.00 | Low | View details for Oppenheimer rating of Main Street Capital (NYSE:MAIN) on 8/13/2024 |
ORIC ORIC Pharmaceuticals | $9.49
-0.1% | 8/13/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $15.00 | Low | View details for Oppenheimer rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 8/13/2024 |
PACS PACS Group | $38.32
-0.4% | 8/13/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $32.00 -> $40.00 | Low | View details for Oppenheimer rating of PACS Group (NYSE:PACS) on 8/13/2024 |
APLE Apple Hospitality REIT | $15.18
+0.5% | 8/12/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $19.00 -> $17.00 | Low | View details for Oppenheimer rating of Apple Hospitality REIT (NYSE:APLE) on 8/12/2024 |
HST Host Hotels & Resorts | $17.46
-0.1% | 8/12/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $24.00 -> $22.00 | Low | View details for Oppenheimer rating of Host Hotels & Resorts (NASDAQ:HST) on 8/12/2024 |
INO Inovio Pharmaceuticals | $5.69
+6.8% | 8/12/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $40.00 -> $33.00 | Low | View details for Oppenheimer rating of Inovio Pharmaceuticals (NASDAQ:INO) on 8/12/2024 |
TARA Protara Therapeutics | $1.74
-1.1% | 8/12/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $30.00 -> $25.00 | Low | View details for Oppenheimer rating of Protara Therapeutics (NASDAQ:TARA) on 8/12/2024 |
VRDN Viridian Therapeutics | $23.40
+0.6% | 8/12/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $31.00 -> $28.00 | Low | View details for Oppenheimer rating of Viridian Therapeutics (NASDAQ:VRDN) on 8/12/2024 |
SLNO Soleno Therapeutics | $51.97
+9.1% | 8/12/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $59.00 -> $65.00 | Low | View details for Oppenheimer rating of Soleno Therapeutics (NASDAQ:SLNO) on 8/12/2024 |
CCSI Consensus Cloud Solutions | $21.46
-0.3% | 8/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $20.00 -> $23.00 | Low | View details for Oppenheimer rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 8/9/2024 |
CRNX Crinetics Pharmaceuticals | $51.70
-0.1% | 8/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $74.00 -> $73.00 | Low | View details for Oppenheimer rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 8/9/2024 |
GCMG GCM Grosvenor | $11.33
-0.3% | 8/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $15.00 -> $14.00 | Low | View details for Oppenheimer rating of GCM Grosvenor (NASDAQ:GCMG) on 8/9/2024 |
IMCR Immunocore | $30.57
-0.6% | 8/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $87.00 -> $89.00 | Low | View details for Oppenheimer rating of Immunocore (NASDAQ:IMCR) on 8/9/2024 |
SG Sweetgreen | $38.19
+9.6% | 8/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $34.00 -> $36.00 | Low | View details for Oppenheimer rating of Sweetgreen (NYSE:SG) on 8/9/2024 |
TARS Tarsus Pharmaceuticals | $34.00
+2.4% | 8/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $61.00 -> $63.00 | Low | View details for Oppenheimer rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 8/9/2024 |
VVI Viad | $35.59
-0.7% | 8/9/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $43.00 -> $41.00 | Low | View details for Oppenheimer rating of Viad (NYSE:VVI) on 8/9/2024 |
PET Wag! Group | $0.88
-3.3% | 8/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $6.00 -> $3.00 | Low | View details for Oppenheimer rating of Wag! Group (NASDAQ:PET) on 8/9/2024 |
AMPX Amprius Technologies | $1.19
-10.5% | 8/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $15.00 -> $14.00 | Low | View details for Oppenheimer rating of Amprius Technologies (NYSE:AMPX) on 8/9/2024 |
ARRY Array Technologies | $6.44
-0.3% | 8/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $20.00 -> $17.00 | N/A | View details for Oppenheimer rating of Array Technologies (NASDAQ:ARRY) on 8/9/2024 |
AORT Artivion | $25.69
-0.4% | 8/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $30.00 | Low | View details for Oppenheimer rating of Artivion (NYSE:AORT) on 8/9/2024 |
BLZE Backblaze | $6.40
+0.8% | 8/9/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $11.00 -> $10.00 | Low | View details for Oppenheimer rating of Backblaze (NASDAQ:BLZE) on 8/9/2024 |
CARG CarGurus | $30.22
+3.5% | 8/9/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $30.00 -> $32.00 | Low | View details for Oppenheimer rating of CarGurus (NASDAQ:CARG) on 8/9/2024 |
HEAR Turtle Beach | $14.97
-1.7% | 8/9/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $17.00 | N/A | View details for Oppenheimer rating of Turtle Beach (NASDAQ:HEAR) on 8/9/2024 |
APP AppLovin | $143.51
+2.5% | 8/8/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $97.00 -> $105.00 | Low | View details for Oppenheimer rating of AppLovin (NASDAQ:APP) on 8/8/2024 |
BLDR Builders FirstSource | $193.48
+0.7% | 8/8/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $230.00 -> $190.00 | Low | View details for Oppenheimer rating of Builders FirstSource (NYSE:BLDR) on 8/8/2024 |
PLYA Playa Hotels & Resorts | $7.92
+1.1% | 8/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $12.00 -> $10.00 | Low | View details for Oppenheimer rating of Playa Hotels & Resorts (NASDAQ:PLYA) on 8/8/2024 |
RXO RXO | $27.62
+1.5% | 8/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $22.00 -> $31.00 | Low | View details for Oppenheimer rating of RXO (NYSE:RXO) on 8/8/2024 |
PRCH Porch Group | $1.40
+0.7% | 8/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $4.50 -> $3.50 | Low | View details for Oppenheimer rating of Porch Group (NASDAQ:PRCH) on 8/8/2024 |
[SHOCKING] Crypto Document Leak… (Ad) The crypto market waits for no one.
And my team of experts and I believe that a BIG move is right around the corner.
That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes. Download your digital copy now |
CEVA CEVA | $24.45
-0.3% | 8/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $29.00 -> $33.00 | Low | View details for Oppenheimer rating of CEVA (NASDAQ:CEVA) on 8/8/2024 |
COST Costco Wholesale | $890.42
+1.9% | 8/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $950.00 -> $925.00 | Low | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 8/8/2024 |
EMR Emerson Electric | $109.42
-2.8% | 8/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $125.00 -> $120.00 | Low | View details for Oppenheimer rating of Emerson Electric (NYSE:EMR) on 8/8/2024 |
ORA Ormat Technologies | $75.27
-0.8% | 8/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $85.00 -> $86.00 | Low | View details for Oppenheimer rating of Ormat Technologies (NYSE:ORA) on 8/8/2024 |
ROK Rockwell Automation | $266.16
-0.4% | 8/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $295.00 -> $270.00 | Low | View details for Oppenheimer rating of Rockwell Automation (NYSE:ROK) on 8/8/2024 |
ALLO Allogene Therapeutics | $2.74
+6.2% | 8/8/2024 | Initiated by | Oppenheimer | - | Outperform | $13.00 -> $11.00 | Low | View details for Oppenheimer rating of Allogene Therapeutics (NASDAQ:ALLO) on 8/8/2024 |
TYRA Tyra Biosciences | $21.64
+3.8% | 8/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $28.00 -> $25.00 | Low | View details for Oppenheimer rating of Tyra Biosciences (NASDAQ:TYRA) on 8/8/2024 |
PLRX Pliant Therapeutics | $11.24
+1.1% | 8/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $45.00 | N/A | View details for Oppenheimer rating of Pliant Therapeutics (NASDAQ:PLRX) on 8/8/2024 |
ZBH Zimmer Biomet | $101.77
-0.5% | 8/8/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $155.00 -> $145.00 | N/A | View details for Oppenheimer rating of Zimmer Biomet (NYSE:ZBH) on 8/8/2024 |
PNTG The Pennant Group | $33.42
+2.6% | 8/8/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $28.00 -> $34.00 | N/A | View details for Oppenheimer rating of The Pennant Group (NASDAQ:PNTG) on 8/8/2024 |
FROG JFrog | $27.40
+0.7% | 8/8/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of JFrog (NASDAQ:FROG) on 8/8/2024 |
AMGN Amgen | $317.68
+0.1% | 8/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $380.00 -> $380.00 | Low | View details for Oppenheimer rating of Amgen (NASDAQ:AMGN) on 8/7/2024 |
GBDC Golub Capital BDC | $15.17
-0.1% | 8/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $17.00 -> $17.00 | Low | View details for Oppenheimer rating of Golub Capital BDC (NASDAQ:GBDC) on 8/7/2024 |
TRMB Trimble | $61.48
0.0% | 8/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $72.00 -> $72.00 | Low | View details for Oppenheimer rating of Trimble (NASDAQ:TRMB) on 8/7/2024 |
OLMA Olema Pharmaceuticals | $11.40
+0.6% | 8/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $30.00 -> $30.00 | Low | View details for Oppenheimer rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 8/7/2024 |
BCYC Bicycle Therapeutics | $23.53
+0.6% | 8/7/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $48.00 -> $48.00 | Low | View details for Oppenheimer rating of Bicycle Therapeutics (NASDAQ:BCYC) on 8/7/2024 |
IDYA IDEAYA Biosciences | $31.06
+5.6% | 8/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $60.00 -> $53.00 | Low | View details for Oppenheimer rating of IDEAYA Biosciences (NASDAQ:IDYA) on 8/7/2024 |
RLAY Relay Therapeutics | $6.25
-1.4% | 8/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $25.00 -> $24.00 | Low | View details for Oppenheimer rating of Relay Therapeutics (NASDAQ:RLAY) on 8/7/2024 |
RUN Sunrun | $16.39
-1.5% | 8/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $19.00 -> $22.00 | Low | View details for Oppenheimer rating of Sunrun (NASDAQ:RUN) on 8/7/2024 |
ADUS Addus HomeCare | $129.02
+3.4% | 8/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $130.00 -> $140.00 | Low | View details for Oppenheimer rating of Addus HomeCare (NASDAQ:ADUS) on 8/7/2024 |
CRBP Corbus Pharmaceuticals | $19.58
+3.1% | 8/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $80.00 -> $88.00 | Low | View details for Oppenheimer rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 8/7/2024 |
NYXH Nyxoah | $9.34
+0.4% | 8/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $15.00 -> $13.00 | Low | View details for Oppenheimer rating of Nyxoah (NASDAQ:NYXH) on 8/7/2024 |
JACK Jack in the Box | $43.98
+0.5% | 8/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $75.00 -> $70.00 | Low | View details for Oppenheimer rating of Jack in the Box (NASDAQ:JACK) on 8/7/2024 |
INGR Ingredion | $134.04
-0.3% | 8/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $126.00 -> $138.00 | N/A | View details for Oppenheimer rating of Ingredion (NYSE:INGR) on 8/7/2024 |
SHLS Shoals Technologies Group | $4.92
-3.5% | 8/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $12.00 | N/A | View details for Oppenheimer rating of Shoals Technologies Group (NASDAQ:SHLS) on 8/7/2024 |
MWA Mueller Water Products | $22.16
-2.8% | 8/7/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $22.00 -> $24.00 | N/A | View details for Oppenheimer rating of Mueller Water Products (NYSE:MWA) on 8/7/2024 |
CTOS Custom Truck One Source | $3.13
-3.1% | 8/7/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $7.00 -> $6.00 | N/A | View details for Oppenheimer rating of Custom Truck One Source (NYSE:CTOS) on 8/7/2024 |
GPRE Green Plains | $13.23
-1.3% | 8/7/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Green Plains (NASDAQ:GPRE) on 8/7/2024 |
RXST RxSight | $49.25
+2.1% | 8/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $72.00 -> $65.00 | Low | View details for Oppenheimer rating of RxSight (NASDAQ:RXST) on 8/6/2024 |
CG The Carlyle Group | $46.67
-0.2% | 8/6/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $69.00 -> $64.00 | Low | View details for Oppenheimer rating of The Carlyle Group (NASDAQ:CG) on 8/6/2024 |
VRTX Vertex Pharmaceuticals | $458.94
+2.3% | 8/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $500.00 -> $550.00 | Low | View details for Oppenheimer rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 8/5/2024 |
DKNG DraftKings | $37.50
-0.8% | 8/5/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $58.00 -> $55.00 | Low | View details for Oppenheimer rating of DraftKings (NASDAQ:DKNG) on 8/5/2024 |
IEX IDEX | $208.41
-0.1% | 8/5/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $245.00 -> $238.00 | Low | View details for Oppenheimer rating of IDEX (NYSE:IEX) on 8/5/2024 |
LSEA Landsea Homes | $11.37
-0.3% | 8/5/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $14.00 -> $15.00 | Low | View details for Oppenheimer rating of Landsea Homes (NASDAQ:LSEA) on 8/5/2024 |
PRAX Praxis Precision Medicines | $64.77
+3.6% | 8/5/2024 | Initiated by | Oppenheimer | - | Outperform | $134.00 | Low | View details for Oppenheimer rating of Praxis Precision Medicines (NASDAQ:PRAX) on 8/5/2024 |
WSC WillScot Mobile Mini | $36.49
-1.9% | 8/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $53.00 -> $46.00 | Low | View details for Oppenheimer rating of WillScot Mobile Mini (NASDAQ:WSC) on 8/2/2024 |
LUMO Lumos Pharma | $3.85
-0.3% | 8/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $16.00 -> $13.00 | Low | View details for Oppenheimer rating of Lumos Pharma (NASDAQ:LUMO) on 8/2/2024 |
IRTC iRhythm Technologies | $60.19
-0.3% | 8/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $165.00 -> $145.00 | Low | View details for Oppenheimer rating of iRhythm Technologies (NASDAQ:IRTC) on 8/2/2024 |
NBIX Neurocrine Biosciences | $111.66
-0.4% | 8/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $216.00 -> $219.00 | Low | View details for Oppenheimer rating of Neurocrine Biosciences (NASDAQ:NBIX) on 8/2/2024 |
DASH DoorDash | $143.30
+0.9% | 8/2/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $125.00 -> $145.00 | Low | View details for Oppenheimer rating of DoorDash (NASDAQ:DASH) on 8/2/2024 |
BKNG Booking | $4,233.18
+1.5% | 8/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $4,600.00 -> $4,200.00 | Low | View details for Oppenheimer rating of Booking (NASDAQ:BKNG) on 8/2/2024 |
TEAM Atlassian | $168.02
+0.3% | 8/2/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $250.00 -> $230.00 | Low | View details for Oppenheimer rating of Atlassian (NASDAQ:TEAM) on 8/2/2024 |
RGLS Regulus Therapeutics | $1.55
-9.4% | 8/2/2024 | Initiated by | Oppenheimer | - | Outperform | $7.00 | Low | View details for Oppenheimer rating of Regulus Therapeutics (NASDAQ:RGLS) on 8/2/2024 |
RANI Rani Therapeutics | $2.19
-3.1% | 8/2/2024 | Initiated by | Oppenheimer | - | Outperform | $17.00 | Low | View details for Oppenheimer rating of Rani Therapeutics (NASDAQ:RANI) on 8/2/2024 |
OCSL Oaktree Specialty Lending | $16.40
+0.4% | 8/2/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | $20.00 -> $18.00 | Low | View details for Oppenheimer rating of Oaktree Specialty Lending (NASDAQ:OCSL) on 8/2/2024 |
OWL Blue Owl Capital | $20.34
-1.8% | 8/2/2024 | Upgraded by | Oppenheimer | - | Market Perform -> Outperform | $21.00 | Low | View details for Oppenheimer rating of Blue Owl Capital (NYSE:OWL) on 8/2/2024 |
CLH Clean Harbors | $251.31
+1.9% | 8/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $245.00 -> $252.00 | Low | View details for Oppenheimer rating of Clean Harbors (NYSE:CLH) on 8/1/2024 |
NGVT Ingevity | $34.54
-3.8% | 8/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $58.00 -> $50.00 | Low | View details for Oppenheimer rating of Ingevity (NYSE:NGVT) on 8/1/2024 |
KKR KKR & Co. Inc. | $131.36
+0.0% | 8/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $121.00 -> $128.00 | Low | View details for Oppenheimer rating of KKR & Co. Inc. (NYSE:KKR) on 8/1/2024 |
MOD Modine Manufacturing | $132.77
-0.5% | 8/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $114.00 -> $135.00 | Low | View details for Oppenheimer rating of Modine Manufacturing (NYSE:MOD) on 8/1/2024 |
NRDS NerdWallet | $12.34
-1.7% | 8/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $20.00 -> $18.00 | Low | View details for Oppenheimer rating of NerdWallet (NASDAQ:NRDS) on 8/1/2024 |
TMDX TransMedics Group | $138.12
+3.0% | 8/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $125.00 -> $200.00 | Low | View details for Oppenheimer rating of TransMedics Group (NASDAQ:TMDX) on 8/1/2024 |
HUM Humana | $243.20
+2.9% | 8/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $370.00 -> $400.00 | Low | View details for Oppenheimer rating of Humana (NYSE:HUM) on 8/1/2024 |
TDOC Teladoc Health | $8.72
+0.8% | 8/1/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $21.00 -> $17.00 | Low | View details for Oppenheimer rating of Teladoc Health (NYSE:TDOC) on 8/1/2024 |
RSI Rush Street Interactive | $10.83
+3.6% | 8/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $10.00 -> $14.00 | Low | View details for Oppenheimer rating of Rush Street Interactive (NYSE:RSI) on 8/1/2024 |
META Meta Platforms | $592.89
+1.4% | 8/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $525.00 -> $615.00 | Low | View details for Oppenheimer rating of Meta Platforms (NASDAQ:META) on 8/1/2024 |
ZETA Zeta Global | $31.85
+4.8% | 8/1/2024 | Target Raised by | Oppenheimer | - | Outperform -> Outperform | $20.00 -> $29.00 | Low | View details for Oppenheimer rating of Zeta Global (NYSE:ZETA) on 8/1/2024 |
ETSY Etsy | $50.83
-0.7% | 8/1/2024 | Downgraded by | Oppenheimer | - | Outperform -> Market Perform | | Low | View details for Oppenheimer rating of Etsy (NASDAQ:ETSY) on 8/1/2024 |
ARVN Arvinas | $25.78
+1.9% | 7/31/2024 | Target Lowered by | Oppenheimer | - | Outperform -> Outperform | $70.00 -> $50.00 | Low | View details for Oppenheimer rating of Arvinas (NASDAQ:ARVN) on 7/31/2024 |
GLW Corning | $44.59
+1.1% | 7/31/2024 | Reiterated by | Oppenheimer | - | Outperform -> Outperform | $50.00 -> $47.00 | Low | View details for Oppenheimer rating of Corning (NYSE:GLW) on 7/31/2024 |
